Taken together, our work demonstrates that MYSM1 is required to sustain the oncogenic activity of cMYC in B cell lymphoma, by promoting the cMYC‐dependent induction of the genes encoding ribosomal proteins and translation factors. Here, MYSM1 is linked to B-cell non-Hodgkin lymphoma.